Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: A multicenter randomized phase III study

Journal of Clinical Oncology

Volumn 15, Issue 5, 1997, Pages 2082-2089

  Pujol, Jean Louis ^a   Douillard, Jean Yves ^a   Rivière, Alain ^a   Quoix, Elisabeth ^a   Lagrange, Jean Léon ^a   Berthaud, Patrice ^a   Bardonnet Comte, Martine ^a   Polin, Valérie ^a   Gautier, Véronique ^a   Milleron, Bernard ^a   Chomy, François ^a   Chomy, Pierre ^a   Spaeth, Dominique ^a   Le Chevalier, Thierry ^a  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; ETOPOSIDE; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE TRANSFUSION;

EID: 0030900127     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.5.2082     Document Type: Article

References (29)

1. Hansen HH, Kristjansen PEG: Chemotherapy of small cell lung cancer. Eur J Cancer 27:342-349, 1991
2. Iannuzzi MC, Scoggin CH: State of art: Small cell lung cancer. Am Rev Respir Dis 134:593-608, 1986
3. Arriagada R, Le Chevalier T, Pignon JP, et al: Initial chemotherapeutic doses and survival in patients with limited small cell lung cancer. N Engl J Med 329:1848-1852, 1993
4. Johnson DH, Greco FA: Review: Small cell lung cancer: Current perspectives. Am J Med Sci 293:377-389, 1987
5. Evans WK, Shepherd FA, Feld D, et al: VP-16 and cisplatin as first line therapy for small cell lung cancer. J Clin Oncol 3:1471-1477, 1985
6. Sculier JP, Klastersky J, Libert P, et al: A phase II study evaluating CAVi (cyclophosphamide, Adriamycin, vincristine) potentiated or not by amphotericin B entrapped into sonicated liposomes, as salvage therapy for small cell lung cancer. Lung Cancer 6:110-118, 1990
7. Arriagada R, Kramar A, Le Chevalier T, et al: Competing events determining relapse-free survival in limited small-cell carcinoma: The French Cancer Centers' Lung Group. J Clin Oncol 10:447-451, 1992
8. Klastersky J: Commentary: Intensive chemotherapy in small cell lung cancer. Eur J Cancer Clin Oncol 25:933-937, 1989
9. Crawford J, Ozer H, Stoller R, et al: Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med 325:164-170, 1991
10. Trillet-Lenoir V, Green J, Manegold C, et al: Recombinant granulocyte colony-stimulating factor reduces the infectious complications of cytotoxic chemotherapy. Eur J Cancer 29:319-324, 1993
11. Hamm J, Shiller JH, Cuffie C, et al: Dose-ranging study of recombinant human granulocyte-macrophage colony-stimulating factor in small-cell lung carcinoma. J Clin Oncol 12:2667-2676, 1994
12. Sobin LH, Hermanek P, Hutter RVP: TNM Classification of Malignant Tumours (ed 4). Geneva, Switzerland, International Union Against Cancer, 1987
13. Tisi GM, Friedman PJ, Peters RM, et al: American Thoracic Society: Clinical staging of primary lung cancer. Am Rev Respir Dis 125:659-664, 1982
14. World Health Organization: WHO Handbook for Reporting the Results of Cancer Treatment. Geneva, Switzerland, WHO, Offset Publication No. 48, 1979
15. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
16. De Vita VT, Young RC, Canellos JP: Combination versus single agent chemotherapy: A review of the basis for selection of drug treatment of cancer. Cancer 35:98-110, 1975
17. Feld R, Evans WK, De Boer G, et al: Combined modality induction therapy without maintenance chemotherapy for small cell carcinoma of the lung. J Clin Oncol 2:294-304, 1984
18. Livingstone RB, Moore TN, Heilbrun L, et al: Small cell carcinoma of the lung combined chemotherapy and radiation: A Southwest Oncology Group Study. Ann Intern Med 88:194-199, 1978
19. Boni C, Cocconi G, Bisagni G, et al: Cisplatin and etoposide (VP 16) as a single regimen for small cell lung cancer: Phase II trial. Cancer 63:638-642, 1989
20. Evans WK, Osoba D, Feld R, et al: Etoposide (VP 16) and cisplatin: An effective treatment for relapse in small cell lung cancer. J Clin Oncol 3:65-71, 1985
21. Osterlind K, Hansen HH, Hansen M, et al: Long-term disease-free survival in small-cell carcinoma of the lung: A study of clinical determinants. J Clin Oncol 4:1307-1313, 1986
22. Lopez JA, Mann J, Grapski RT, et al: Etoposide and cisplatin salvage chemotherapy for small cell lung cancer. Cancer Treat Rep 69:369-371, 1985
23. Porter LL, Johnson DH, Hainsworth JD, et al: Cisplatin and etoposide combination chemotherapy for refractory small cell carcinoma of the lung. Cancer Treat Rep 69:479-481, 1985
24. Goldie JH, Coldman AJ: Application of theoretical models to chemotherapy protocol design. Cancer Treat Rep 70:127-131, 1986
25. Bunn PA, Crowley J, Kelly K, et al: Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: A prospective phase III randomized study of the Southwest Oncology Group. J Clin Oncol 13:1632-1642, 1995
26. Idhe DC, Mulshine JL, Kramer BS, et al: Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer. J Clin Oncol 12:2022-2034, 1994
27. Miles DW, Fogarty O, Ash CM, et al: Received dose-intensity: A randomized trial of weekly chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer. J Clin Oncol 12:77-82, 1994
28. Steward WP, Von Pawel J, Gatzemeier U, et al: Dose intensification of V-ICE chemotherapy with GM-CSF in small cell lung cancer (SCLC): A prospective randomized study of 301 patients. European Conference on Clinical Oncology. Eur J Cancer 31S:A80, 1995 (suppl; abstr)
29. Avalos BR, Gasson JC, Hedvat C, et al: Human granulocyte colony-stimulating factor: Biologic activities and receptor characterization on hematopoietic cells and small cell lung cancer cell lines. Blood 75:851-857, 1990